title: Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia.
authors.affiliation: Department of Cardiac Surgery, Albertinen-Hospital, Hamburg, Germany. herzchirurgie@albertinen.de
authors.forename: F C
authors.initials: FC
authors.lastname: Riess
authors.forename: M
authors.initials: M
authors.lastname: Fiege
authors.forename: S
authors.initials: S
authors.lastname: Moshar
authors.forename: H
authors.initials: H
authors.lastname: Bergmann
authors.forename: N
authors.initials: N
authors.lastname: Bleese
authors.forename: J
authors.initials: J
authors.lastname: Kormann
authors.forename: R
authors.initials: R
authors.lastname: Weisshorn
authors.forename: F
authors.initials: F
authors.lastname: Wappler
mesh_terms: D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D000242:Cyclic AMP / Q000502:physiology; D017335:Enoximone / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000150:complications*; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000209:etiology*
chemical_list: D010726:Phosphodiesterase Inhibitors; D017335:Enoximone; D000242:Cyclic AMP